Wednesday, March 14, 2007
ProteoGenix Gets $20M B
Portland, Oregon-based ProteoGenix, a firm which is developing genomic and high-throughput protein analytical techniques for the diagnostic testing for maternal-fetal health, has received $20M in a Series B funding. Accoridng to New Leaf Venture Partners and TPG Growth, the firms co-led the $20M Series B round in ProteoGenix. Vijay Lathi of NLV, Fred Cohen of TPG, and G. Steven Burrill of Burril and Company have joined the firm's board of directors. More information »